FNY Investment Advisers LLC Has $3.62 Million Stake in Kenvue Inc. $KVUE

FNY Investment Advisers LLC raised its position in shares of Kenvue Inc. (NYSE:KVUE) by 36.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 209,659 shares of the company’s stock after acquiring an additional 56,342 shares during the quarter. Kenvue comprises 1.0% of FNY Investment Advisers LLC’s investment portfolio, making the stock its 17th biggest holding. FNY Investment Advisers LLC’s holdings in Kenvue were worth $3,616,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in KVUE. Van ECK Associates Corp lifted its stake in shares of Kenvue by 101.3% in the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after purchasing an additional 9,240,434 shares during the period. American Century Companies Inc. grew its stake in Kenvue by 22.4% during the third quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after purchasing an additional 6,781,640 shares during the period. Amundi increased its holdings in Kenvue by 82.5% in the second quarter. Amundi now owns 14,509,890 shares of the company’s stock worth $305,446,000 after purchasing an additional 6,559,261 shares in the last quarter. Mondrian Investment Partners LTD bought a new stake in Kenvue in the third quarter worth approximately $79,269,000. Finally, Alliancebernstein L.P. lifted its stake in Kenvue by 115.9% in the second quarter. Alliancebernstein L.P. now owns 6,438,473 shares of the company’s stock valued at $134,757,000 after buying an additional 3,456,204 shares during the period. 97.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the company from $23.00 to $18.00 in a research report on Friday, January 30th. Canaccord Genuity Group increased their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Barclays raised their price target on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Friday, March 6th. Finally, UBS Group upped their price objective on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Kenvue has an average rating of “Hold” and a consensus price target of $19.58.

Kenvue Stock Performance

Shares of KVUE stock opened at $17.16 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. The firm has a 50-day moving average of $18.00 and a 200-day moving average of $17.10. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The company has a market cap of $32.90 billion, a P/E ratio of 22.29, a P/E/G ratio of 3.95 and a beta of 0.61.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The business had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $3.68 billion. During the same period in the previous year, the company earned $0.26 earnings per share. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. Equities research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date was Wednesday, February 11th. Kenvue’s payout ratio is presently 107.79%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.